| Literature DB >> 34750488 |
Daniel Göhler1,2, Ralf Gritzki3, Antje Geldner4,5, Franz Lohse1, Stephan Große2, Julien Sobilo6, Clemens Felsmann3, Jonathan R Buggisch6,7, Alain Le Pape6, Andreas Rudolph2, Michael Stintz1, Urs Giger-Pabst7,8.
Abstract
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a promising approach with a high optimization potential for the treatment of peritoneal carcinomatosis. To study the efficacy of PIPAC and drugs, first rodent cancer models were developed. But inefficient drug aerosol supply and knowledge gaps concerning spatial drug distribution can limit the results based on such models. To study drug aerosol supply/deposition, computed tomography scans of a rat capnoperitoneum were used to deduce a virtual and a physical phantom of the rat capnoperitoneum (RCP). RCP qualification was performed for a specific PIPAC method, where the capnoperitoneum is continuously purged by the drug aerosol. In this context, also in-silico analyses by computational fluid dynamic modelling were conducted on the virtual RCP. The physical RCP was used for ex-vivo granulometric analyses concerning drug deposition. Results of RCP qualification show that aerosol deposition in a continuous purged rat capnoperitoneum depends strongly on the position of the inlet and outlet port. Moreover, it could be shown that the droplet size and charge condition of the drug aerosol define the deposition efficiency. In summary, the developed virtual and physical RCP enables detailed in-silico and ex-vivo analyses on drug supply/deposition in rodents.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34750488 PMCID: PMC8575922 DOI: 10.1038/s41598-021-01332-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Phantom of the rat capnoperitoneum: (a) anesthetized rat, (b) respiration-triggered computed tomography scan of rat capnoperitoneum in supine position at a capnoperitoneal pressure of pc,rat = 1.07 kPa = 8 mmHg; (c) surface mesh of final virtual rat capnoperitoneum phantom.
Figure 2Rat capnoperitoneum phantom: (a) CAD model in different views and (b) photograph of bottom part (i.e., visceral peritoneum) and upper part (parietal peritoneum) of the model after additive manufacturing by 3D filament printing.
Studied scenarios for drug aerosol supply to the rat capnoperitoneum phantoms (RCP).
| Phantom (–) | Volume (mL) | Flow rate (SL/min) | Pressure drop (mbar) | Residence timea (s) | Purging direction (–) | Chargeb (–) |
|---|---|---|---|---|---|---|
| Virtual RCP | 146.2 ± 0.00 | 1.0 | n/a | 8.77 ± 0.00 | Top-down, bottom-up | n/a |
| 3.0 | 2.92 ± 0.00 | Top-down, bottom-up | ||||
| 5.0 | 1.75 ± 0.00 | Top-down, bottom-up | ||||
| Physical RCP | 130.85 ± 3.89 | 1.0 | 0.08 ± 0.029 | 7.85 ± 0.24 | Top-down | +/−, + |
| 3.0 | 0.60 ± 0.000 | 2.62 ± 0.08 | Top-down | +/−, + | ||
| 5.0 | 1.72 ± 0.076 | 1.57 ± 0.05 | Top-down | +/−, + | ||
| Alternative RCP | 134.65 ± 0.43 | 1.0 | 0.07 ± 0.029 | 8.08 ± 0.03 | Top-down | + |
| 3.0 | 0.43 ± 0.058 | 2.69 ± 0.01 | Top-down | + | ||
| 5.0 | 0.88 ± 0.029 | 1.62 ± 0.01 | Top-down | + |
aRatio of inner RCP volume and air/aerosol flow rate that describes the mean period of time a discrete volume passes the RCP.
bi.e., aerosol charge condition; + / − … bipolar neutralized aerosol, + … macroscopic positively charged aerosol.
Figure 3Schematic diagram of the experimental setup for deposition efficiency analyses on the physical rat capnoperitoneum phantom and the alternative phantom.
Figure 4In-silico CFD analysis: mean flow velocity (and flow vectors) in (a) coronal sectional plane and (b) sagittal sectional plane for top-down and bottom-up purging; black circles indicate position/size of inlet/outlet ports; black triangles indicate flow direction.
Figure 5In-silico CFD analysis: (a) nondimensional air/aerosol age at visceral peritoneum (left-dorsal-right view); (b) nondimensional air/aerosol age at parietal peritoneum (right-ventral-left view).
Figure 6Granulometric results based on ex-vivo/situ aerosol analysis on the physical RCP: (a) mean (n = 3) particle size distributions at inlet (SP1) and outlet (SP2) at a volumetric flow rate of 3 l/min; (b) separation efficiency data over particle size and corresponding semi-empirical function for a volumetric air flow rate of 3 l/min of the bipolar charged test aerosols; confidence range refers to the size range of adequate measurement data (suggested for data interpolation).
Figure 7Granulometric results based on ex-vivo aerosol analysis with bipolar neutralized (+/−) and macroscopic positive charged (+) aerosols: impact of the volumetric air flow rate on the separation efficiency within the (a) physical RCP and the (b) alternative RCP.
Studied scenarios for drug aerosol supply to the rat capnoperitoneum phantoms (RCP).
| Phantom | Flow rate (L/min) | Chargea (–) | A (µm) | B (–) | C (µm−2) | R2b (–) | MPPSc (nm) |
|---|---|---|---|---|---|---|---|
| Physical RCP | 1 | +/− | 1.69E−3 | 3.53E−1 | 8.94E−3 | 0.35 | 447 |
| 3 | +/− | 9.03E−4 | 4.52E−1 | 1.02E−2 | 0.81 | 355 | |
| 5 | +/− | 7.55E−4 | 4.32E−1 | 2.24E−2 | 0.71 | 251 | |
| Physical RCP | 1 | + | 2.37E−3 | 9.75E−2 | 2.73E−2 | 0.40 | 355 |
| 3 | + | 3.28E−3 | 9.31E−2 | 1.21E−1 | 0.45 | 251 | |
| 5 | + | 3.23E−3 | 1.78E−1 | 6.93E−2 | 0.56 | 282 | |
| Alternative RCP | 1 | + | 8.72E−3 | 3.36E−2 | 8.20E−2 | 0.91 | 398 |
| 3 | + | 3.32E−3 | 3.11E−2 | 2.36E−2 | 0.80 | 398 | |
| 5 | + | 2.12E−3 | 2.04E−2 | 5.39E−2 | 0.65 | 282 |
ai.e., aerosol charge condition; + / − … bipolar neutralized aerosol, + … macroscopic positively charged aerosol.
bR2 = coefficient of determination.
cMPPS = most penetrating particle size.
Figure 8Estimation of particle deposition for bipolar neutralized (+/−) aerosols within the physical RCP on the basis of given size distribution data: (a) calculated lognormal size distribution data for two different aerosols with corresponding fractional amounts of deposited particles and (b) overall separation efficiency for both aerosols.